San Diego medtech startup Clarify Medical got the green light from regulators to sell its light therapy system to patients, the company announced Tuesday.
The startup, founded in 2014, makes a hand-held UVB light device that can be used to treat skin conditions such as psoriasis and eczema. The mobility of the device allows patients to treat their conditions at home instead of visiting doctors or clinics several times a week.
The company, founded by Martyn Gross and incubated at EvoNexus, recently adopted senior leadership at the C-level. Gross stepped down from his position as CEO in 2016 when the company brought in serial entrepreneur James Sweeney for the role. A few months later, Clarify announced a $3.6 million round of funding.
Clarify has now received market clearance from the U.S. Food and Drug Administration for the company’s phototherapy system (the core technology used in the device). The startup said they plan to sell the product to patients by this November, and already have 1,000 customers lined up.
The company is currently raising a $10 million Series A round to help support the product launch. In a statement, the company said it expects to close the offering “in the near future.”